CONRIG PHARMA ApS: Financial statements 2024
CVR: 33373236
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -92,016 and a net result of DKK -100,217 compared with DKK -510,872 the year before. Equity in the 2024 report amounted to DKK 24,543. The solvency ratio was 35.4%.
- Gross Profit
- DKK -92,016
- Profit/Loss
- DKK -100,217
- Equity
- DKK 24,543
- Total Assets
- DKK 69,390
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -92 t. | -100 t. | 25 t. | - |
| 2023 | - | -506 t. | -511 t. | -102 t. | - |
| 2022 | - | 1.3 mio. | 1.2 mio. | 409 t. | - |
| 2021 | - | -246 t. | -308 t. | -1.7 mio. | - |
| 2020 | - | -555 t. | -604 t. | -1.4 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
CONRIG PHARMA ApS has published its annual report for 2023. Gross profit came to DKK -506,147, and the net result was DKK -510,872.
About CONRIG PHARMA ApS
CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Lars Christer Fredrik Fåhraeus and Snickar Karl Johan Tobieson. The board consists of Lars Christer Fredrik Fåhraeus, Niels Skjærbæk and Snickar Karl Johan Tobieson. The company is owned by Melius Pharma AB. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.